Band
Level 7
Job Description Summary
Location: Basel, Switzerland #LI-HybridPurpose of the role:
Our ambition is to be leaders in Cell & Gene across international markets through the development of assets across different targets in Hematology but also across TAs.
The International ED Pre-Launch Assets Cell & Gene Platform provides the pan-TA vision, strategy and operational leadership for the commercial development of the next generation assets of the Cell & Gene platform (T-Charge). The role is responsible for evaluating all strategic options to ensure viable long-term financial funding for the platform as well as fostering a strong CAR-T community pan-TA
The International ED Pre-Launch Assets C&G, plays a pivotal role in leading the end-to-end brand strategy, encompassing the vision, development, orchestration, implementation, and evaluation of integrated YTB323 strategies in Hematology across major international markets. The ED will also lead the development of the right CAR-T platform strategy to support the success of YTB323, and future assets, across different TA.
As an enterprise leader, the ED will focus on the top three countries (Germany, Japan, and China) and Regions, driving the successful launch and growth of YTB323 in Hematology and the platform strategy for all indications.
The incumbent will collaborate closely with Global Drug Development (GDD), International/Global Medical Affairs, Value & Access, S&G, NTO and Customer & Market Activation teams to drive consistent strategy development and execution. This role represents the commercial team across different instances of the organization.
Job Description
Major Accountabilities
Accountable of delivery for all TA pipeline and BD&L activities through:
Direct commercial input for YTB323 development program through the active participation in the Global Product Team for Hematology and extended GPT member for other indications. Build the FDP case and present to Senior Leadership for endorsement.
Represent the interests of the International markets to ensure development program results in maximal access for key International countries (DE, JP, CN (continued monitoring and assessment of potential).
Collaborate closely with global development and US team to refine target product profile.
Collaborate with US team to assess global business potential (opportunity sizing and forecasting) to maximize commercialization & patient access potential.
CAR-T enterprise strategy (Pan-TA) – liaise with cross functional stakeholders to execute platform strategy to exploit synergies and maximize success across the organization for CAR-T therapies.
Collaborate with GMA to support to maximize patient access potential.
Strong collaboration with Strategy & Growth to provide early commercial inputs into the pipeline development.
Strong relationship with US TA to ensure an aligned commercial voice is presented to leadership.
International Launch Strategy: Lead the development and implementation of the launch plan for the assigned indication, ensuring alignment with overall asset strategy and corporate objectives.
Cross-Functional Leadership: Orchestrate a global/international, cross-functional team (Medical, Regulatory, Access, Commercial, Supply, etc.) to deliver seamless launch execution.
Insight Integration: Leverage market research, competitive intelligence, and stakeholder feedback to refine positioning, messaging, and tactical planning.
International-Local Partnership: Partner closely with regional and country teams to ensure pull-through of global strategy, providing guidance and tools to support in-market success.
Milestone Tracking & Governance: Define and track critical launch milestones and KPIs; lead governance updates and ensure timely decision-making across key forums (including FDP transition).
Stakeholder Engagement: Effectively communicate T Charge platform vision and strategic goals to senior leaders, including the International Leadership Team (ILT), Country Presidents (CP), and regional heads.
Compliance & Excellence: Uphold the highest standards of compliance and launch excellence throughout all activities.
Lead and support C&G pipeline director to build and execute aligned strategic objectives.
What you’ll bring to the role:
Master’s degree in Business, Science, or a related field, PH D, MD & MBA desirable
Full professional proficiency in English
+10 years of commercial experience across various functions in countries and above country, demonstrating a broad and deep understanding of the commercial landscape
Proven track record of successful launches, with commercial leadership experience and therapeutic area (TA) leadership in core markets
Extensive commercial experience in oncology
People management expertise (direct and indirect)
Experience with high-performing/high-growth brands or markets, with a clear understanding of key drivers that influence shifting customer and patient behaviors to ensure successful asset launches
Proficient in translating scientific data into differentiated brand value propositions, enabling impactful launches across pre-launch through lifecycle management (LCM)
Strong track record in collaborating and partnering with cross-unit, cross-functional & key markets to achieve strategic and performance targets
Why Novartis?
Helping people with disease and their families takes more than innovative science. It takes a community of smart, passionate people like you. Collaborating, supporting and inspiring each other. Combining to achieve breakthroughs that
change patients’ lives. Ready to create a brighter future together? https://www.novartis.com/about/strategy/people-and-culture
Disclaimer*: Some restrictions on flexible working options may apply and will be discussed during interview if applicable
Benefits and Rewards:
Read our handbook to learn about all the ways we’ll help you thrive personally and professionally: https://www.novartis.com/careers/benefits-rewards
Commitment to Diversity and Inclusion / EEO:
Novartis is committed to building an outstanding, inclusive work environment and diverse teams representative of the patients and communities we serve.
Accessibility and accommodation:
Novartis is committed to working with and providing reasonable accommodation to all individuals. If, because of a medical condition or disability, you need a reasonable accommodation for any part of the recruitment process, or in order to receive more detailed information about the essential functions of a position, please send an e-mail to [email protected] and let us know the nature of your request and your contact information. Please include the job requisition number in your message.
Join our Novartis Network:
If this role is not suitable to your experience or career goals but you wish to stay connected to hear more about Novartis and our career opportunities, join the Novartis Network here: https://talentnetwork.novartis.com/network
Skills Desired
